Prognosis
Rise of Variants Sparks Push for All-in-One Covid Vaccines
- Version first seen in South Africa can partially evade shots
- In race against the virus, ‘we’ve got to get ahead of it’
This article is for subscribers only.
We're tracking the latest on the coronavirus outbreak and the global response. Sign up here for our daily newsletter on what you need to know.
Just weeks into the rollout of vaccines to combat Covid-19, researchers are shifting their focus to a new class of potential shots to take on the threat posed by fast-spreading mutations.